Mountain View, CA, United States of America

Federico C A Gaeta

This inventor holds 24 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents, primarily in Cancer Immunotherapy. Top assignees: Avanir Pharmaceuticals, Geron Corporation, Sierra Sciences, Inc.. Active years: 2002-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Federico C A Gaeta. Retrieved from https://idiyas.com/inventor/federico-c-a-gaeta

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24

% Patents Active = 25.0

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 3.7

ph-index = 5

Forward Citations = 109(Granted Patents)

Company Filing History:

13 out of 38

Avanir Pharmaceuticals

Sierra Sciences, Inc.

Ancestry.com Dna, LLC

patents

6. 1 out of 1

Avanir Pharmaceutials

Years Active: 2002-2025

Loading Chart...

Areas of Expertise:

Telomerase Reverse Transcriptase

Macrophage Migration Inhibitory Factor

Cancer Treatment

Dendritic Cell Vaccine

Inhibitors

Compounds

Sample Collection

Cellular Vaccine

8-Hydroxy Quinoline

Enantiomeric Compositions

Cancer Cells

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12404304 - Telomerase reverse transcriptase (TERT) expression enhancing compounds and methods for using the same (2025-09-02),

2. 12168019 - 8-hydroxy quinoline derivatives for enhancing telomerase reverse transcriptase (TERT) expression (2024-12-17),

3. 11701374 - 8-hydroxy quinoline derivatives for enhancing telomerase reverse transcriptase (TERT) expression (2023-07-18),

4. 9732376 - Sample collection device (2017-08-15),

5. 8119657 - Enantiomeric compositions of 2-amino-1-(2-isopropylpyrazolo[1,5-α]pyridin-3-yl)propan-1-one and related methods (2012-02-21),

6. 7824849 - Cellular telomerase vaccine and its use for treating cancer (2010-11-02),

7. 7732146 - Method for screening an agent that modulates activity of macrophage migration inhibitory factor (2010-06-08),

8. 7622256 - Method for selecting compounds that modulate MIF-induced expression of ICAM-1 and/or VCAM-1 (2009-11-24),

9. 7585875 - Substituted pyrazolo[1,5-a]pyridine compounds and their methods of use (2009-09-08),

10. 7514225 - Method for screening an agent that modulates activity of macrophage migration inhibitory factor (2009-04-07),

11. 7435737 - Inhibitors of macrophage migration inhibitory factor and methods for identifying the same (2008-10-14),

12. 7432374 - Inhibitors of macrophage migration inhibitory factor and methods for identifying the same (2008-10-07),

13. 7402307 - Method for identifying and killing cancer cells (2008-07-22),

14. 7238809 - Process for the preparation of inhibitors of macrophage migration inhibitory factor (2007-07-03),

15. 7235565 - Inhibitors of macrophage migration inhibitory factor and methods for identifying the same (2007-06-26),

Title: The Inventive Journey of Federico C A Gaeta: Enhancing Health Innovations

Introduction: Federico C A Gaeta, a prolific inventor based in Mountain View, CA, has made significant strides in the field of healthcare with his groundbreaking patents. With an impressive portfolio of 22 patents, Federico is renowned for his contributions to enhancing telomerase reverse transcriptase (TERT) expression and designing innovative sample collection devices.

Latest Patents: Federico's latest patents exemplify his commitment to advancing medical technologies. "8-hydroxy quinoline derivatives for enhancing telomerase reverse transcriptase (TERT) expression" focuses on compounds that boost TERT expression for various applications. Meanwhile, the "Sample collection device" introduces a user-friendly tool for at-home sample collection and DNA analysis.

Career Highlights: Federico has lent his expertise to esteemed companies like Avanir Pharmaceuticals and Geron Corporation. His tenure at these organizations has been marked by a dedication to pushing the boundaries of medical research and developing practical solutions for healthcare challenges.

Collaborations: Throughout his career, Federico has collaborated with talented professionals such as Andrew J Baird and Jerry Anchin. Together, they have pooled their knowledge and skills to drive innovation and bring novel ideas to fruition.

Conclusion: Federico C A Gaeta's inventive spirit and ingenuity continue to shape the landscape of healthcare innovation. His pioneering work in TERT expression enhancement and sample collection devices showcases his unwavering commitment to improving health outcomes and revolutionizing medical practices.

Profile summary based on public USPTO records.